Table 1 Patients characteristics, timing and type of CMV infection/disease and of recurrence

1

64

M

Liver

Cirrhosis Child C

VGC^c

8.9

Colitis

-1.2

Yes (34 days)

No

tacrolimus (10 μg/l)^d

19.02.2005

Alpha-antitrypsin deficiency

450 mg bid

(definite)

prednisone (7.5 qd)

6 months

MMF^e (stop for 1.5 months)

2

53

F

Cardiac

Idiopathic dilated

VGC

6.2

Colitis

-1.3

No

No

cyclosporine (200 μg/l)^d

26.05.2005

cardiomyopathy

450 mg bid

(definite)

prednisone (10 mg qd)

3 months

MMF^e (1000 mg bid)

3

46

M

Kidney

Drug toxicity:

VGC

24.5

Syndrome

-1.8

Yes (29 days)

No

tacrolimus (7 μg/l)^d

11.10.2004

cisplatin, ifosfamide, contrast

450 mg qd

(probable)

prednisone (5 mg qd)

products, non steroidal analgesics

3 months

MPS^f (180 mg bid)

4

62

M

Kidney

Hepatorenal polykystosis

VGC

9.4

Syndrome

-1.2

No

Syndrome (probable)

tacrolimus (8 μg/l)^d

24.03.2006

450 mg qd

(probable)

(21 days)

prednisone (5 mg qd)

3 months

Colitis (definite)

(45 days)

MMF^e (500 mg bid)

5

49

M

Liver

Cirrhosis Child A

None

1.4

Asymptomatic

-0.8

Yes (28 days)

No

cyclosporine (240 μg/l)^d

03.07.2007

Hepatocellular carcinoma (HCV)

infection

prednisone (15 mg qd)

AZA^g (150 mg qd)

6

64

M

Kidney

Hepatorenal polykystosis

VGC

9.7

Syndrome ^h

-0.8

Yes (82 days)

No

tacrolimus (8 μg/l)^d

13.12.2006

450 mg qd

(probable)

prednisone (10 mg qd)

3 months

MMF^e (750 mg bid)

7

68

M

Kidney

Hypertension

VGC

4.4

Syndrome

0

Yes (42 days)

Gastritis (definite)

tacrolimus (7 μg/l)^d

01.12.2006

450 mg qd

(probable)

(62 days)

prednisone (5 mg qd)

3 months

MMF^e (250 mg bid)